Characterisation of the immune sequelae of post-transplant azacitidine and lenalidomide in patients with relapsed AML

Project Details

Short titleCharacterisation of the immune sequelae of post-transplant azacitidine and lenalidomide in patients with relapsed AML
StatusFinished
Effective start/end date1/10/1530/09/17

Funding

  • BLOODWISE